New Students Offer - Use Code HELLO

Register Now

Paxzen: A Generic COVID19 Tablet

Published on September 10, 2022
Current Context: Hyderabad-based drug company Zenara Pharma announced the launch of Paxzen tablets as a treatment option for patients with mild to moderate symptoms of Covid-19.
Paxzen: A Generic COVID19 Tablet
  • It is a generic version of Pfizer’s COVID-19 oral drug Paxlovid.
  • Pfizer’s Paxlovid got approval from the US Food and Drug Administration (FDA), in 2021.
  • The generic version, Paxgen, will contain a combination of two tablets, namely, Nirmatrelvir and Ritonavir.
  • The combination of these tablets will assist patients with mild to moderate symptoms of COVID-19.
  • A box of Paxzen will contain 20 tablets of Nirmatrelvir 150mg and 10 tablets of Ritonavir 100mg and the Maximum Retail Price (MRP) will be Rs. 5200 per box.
  • Zenara Pharma is a fully-owned subsidiary of Hyderabad-based Biophore India Pharmaceuticals and was incorporated in 2004. The Co-founder and Managing Director of Zenara Pharma are Jagadeesh Babu Rangisetty.

Question:

Q.1 The oral tablet for COVID19, Paxgen, will be manufactured by?
a. Serum Institute of India
b. Bharat Biotech
c. Zenara Pharma
d. Moderna

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu